<i>In vitro</i> activity of aztreonam-avibactam and comparators against <i>Enterobacterales</i> isolated from bloodstream infections: ATLAS/ surveillance, 2021-2022. [PDF]
Rossolini GM +6 more
europepmc +1 more source
<i>In vitro</i> activity of aztreonam-nacubactam and cefepime-nacubactam against a global collection of clinically important Gram-negative Bacilli collected in 2021-2023. [PDF]
Karlowsky JA +4 more
europepmc +1 more source
Detection of carbapenem resistance mechanisms in difficult-to-treat Pseudomonas aeruginosa clinical isolates from a tertiary care hospital in Egypt. [PDF]
Salem D +10 more
europepmc +1 more source
Ceftazidime-avibactam activity against urinary carbapenem resistance <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> isolates. [PDF]
Salmanzadeh-Ahrabi S +2 more
europepmc +1 more source
<i>In vitro</i> susceptibility of <i>Stenotrophomonas maltophilia</i> and other carbapenem non-susceptible Gram-negative rods in the Pacific Northwest to cefiderocol and aztreonam-avibactam. [PDF]
Bryan A +8 more
europepmc +1 more source
Emergence of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae with Penicillin-Binding Protein 3 Insertions, Taiwan, 2021. [PDF]
Long T +6 more
europepmc +1 more source
Treatment and outcomes of difficult-to-treat Stenotrophomonas maltophilia pneumonia in the intensive care unit: a multinational retrospective cohort study. [PDF]
Mokrani D +31 more
europepmc +1 more source

